Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Medicine and Surgery (2012)|December 11, 2025
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuriaHarshika Khaim Chandani, Sahira, Syeda Fadak Zahra Hujjat, et al.
Annals of Medicine and Surgery (2012)|January 7, 2026
Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1Zainab Arif, Erum Siddiqui, Syeda Fadak Zahra Hujjat, et al.
Annals of Medicine and Surgery (2012)|July 11, 2026
Garadacimab and the future of hereditary angioedema prophylaxis: a step upstream in the bradykinin pathwayHarshika Khaim Chandani, Syeda Fadak Zahra Hujjat, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Bruton's tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease-modifying strategySyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Muhammad Saad Khan, et al.
Annals of Medicine and Surgery (2012)|January 7, 2026
Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosisSyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuriaHarshika Khaim Chandani, Syeda Fadak Zahra Hujjat, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Metabolic miracle or misguided shift? Tirzepatide in the era of obstructive sleep apnea (OSA)Devya Khaim Chandani, Harshika Khaim Chandani, Muhammad Saad Khan, et al.
Pageof 1